← FDA Drug Approvals (Drugs@FDA)

DOLUTEGRAVIR SODIUM

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: CIPLA LTD · Approved 2018-03-05

Drug application

FDA Application #

ANDA209658

Application type

Abbreviated New Drug Application (Generic)

Brand name

DOLUTEGRAVIR SODIUM

Generic name

Dolutegravir Sodium

Active ingredients

DOLUTEGRAVIR SODIUM

Dosage form

TABLET

Route

ORAL

Marketing status

None (Tentative Approval)

Sponsor

CIPLA LTD

First approval

2018-03-05

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown